Claus-michael Lehr
Department of Pharmaceutics and Pharmaceutical Chemistry
Saarland University
Germany
Biography
Research experience- Mar 2012– present Adjunct Professor University of Utah · Department of Pharmaceutics and Pharmaceutical Chemistry United States · Salt Lake City Dec 2009– Nov 2016 Head of Department Helmholtz Institute for Pharmaceutical Research Saarland · Department of Drug Delivery Germany · Saarbrücken Dec 2009– present Head of Department Helmholtz Centre for Infection Research · Department of Drug Delivery (DDEL) Germany Dec 2009– Nov 2016 Head of Department Helmholtz Institute for Pharmaceutical Research Saarland · Department of Drug Delivery Germany · Saarbrücken May 1995– present Professor Universität des Saarlandes · Department of pharmacy · Biopharmaceutics and Pharmaceutical Technology Germany · Saarbrücken Oct 1993– Apr 1995 Professor (Associate) Philipps-Universität Marburg · Institut für Pharmazeutische Technologie und Biopharmazie Germany · Marburg an der Lahn Sep 1992– Sep 1993 Postdoc Leiden University · Leiden Amsterdam Center for Drug Research · Pharmacrutical Technology Netherlands · Leiden Jul 1991– Jun 1992 PostDoc Position University of Southern California · School of Pharmacy · Vincent HL Lee United States · Los Angeles
Research Interest
Pharmacy, Drug Delivery, Nanomedicine.
Publications
-
Selo MA, Nickel S, et al.Expression and Activity of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Distal Lung Epithelial Cells In Vitro. Pharmaceutical Research. 2017
-
Melero A, Draheim C, et al. Targeted delivery of Cyclosporine A by polymeric nanocarriers improves the therapy of inflammatory bowel disease in a relevant mouse model.European journal of pharmaceutics and biopharmaceutics. 2017.
-
Mittal A, Schulze K, Ebensen T, Weißmann S, Hansen S, et al. Efficient nanoparticle-mediated needle-free transcutaneous vaccination via hair follicles requires adjuvantation. Nanomedicine. 2015.11:147-54
